US FDA News: Extracorporeal Photopheresis (ECP) Treatment : Letter to Health Care Providers - Death and Pulmonary Embolism

FDA has received seven reports of patients experiencing PE during, or soon after, a treatment.
Read more: Extracorporeal Photopheresis (ECP) Treatment : Letter to Health Care Providers - Death and Pulmonary Embolism